← Open Payments lookup

JULIA COLANGELI: Open Payments

NPI 1659016277 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,179 in 151 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $689 · 2025 $3,179

Food & beverage: $3,095Education: $84
CompanyPaymentsAmount
ABBVIE INC.35$656
Salix Pharmaceuticals, a division of Bausch Health US, LLC24$484
Takeda Pharmaceuticals U.S.A., Inc.13$367
Madrigal Pharmaceuticals14$302
Janssen Biotech, Inc.15$301
Daiichi Sankyo Inc.6$172
Ardelyx, Inc.9$143
Ipsen Biopharmaceuticals, Inc4$104
Intercept Pharmaceuticals, Inc.5$102
GENZYME CORPORATION5$100

Products named: XIFAXAN, ENTYVIO, REZDIFFRA, TREMFYA, RINVOQ, DUPIXENT, INJECTAFER, SKYRIZI.

Industry payments across PA — which companies pay providers there.